The Industry
The market for purpose-bred beagles — who breeds them, who buys them, how much it costs, and why demand persists despite alternatives.
42,880
dogs in US labs
FY2024
Source: USDA APHIS
97.3%
are beagles
UK data (only jurisdiction tracking breed)
$1,100
per dog (acquisition)
<0.2% of study cost
$320K–$1M
per study
90-day to chronic
The Supply Chain
Step 1
Breeders
Class A licensed
Marshall, (Ridglan closing)
Step 2
CROs
Contract labs
Charles River, Labcorp, Inotiv
Step 3
Pharma / Gov
End customers
Drug companies, NIH, EPA
Step 4
Testing
Weeks to years
Tox, safety pharm, PK
Step 5
Endpoint
~95% killed
Regulatory data requires necropsy
Market Structure
Breeders (Class A)
Contract Research Organizations (CROs)
Charles River Laboratories
Largest CRO globally. Major beagle consumer.
Labcorp Drug Development
Formerly Covance. Significant dog study capacity.
Inotiv
Acquired Envigo. RMS + Discovery services.
Economics
Key Finding
The dog is the cheapest part of the study. At ~$1,100 per animal, the beagle represents less than 0.2% of the total cost of a 90-day toxicology study ($320K) or a chronic study ($1M+). This means even a significant increase in dog prices would barely affect study economics — and explains why the industry tolerates supply consolidation.
Acquisition cost per dog
~$1,100
Marshall/Envigo average
Production cost per dog
~$2,300
COGS estimate
Dogs per 3-year drug program
~150
Typical non-rodent program
| Study Type | Duration | Dogs Required | Estimated Cost |
|---|---|---|---|
| Acute toxicology | Single dose + 14 days | 8-16 | ~$150K |
| 90-day subchronic (OECD 409) | 90 days | 32-48 | ~$320K |
| Chronic toxicology | 6-12 months | 40-64 | ~$1M+ |
| Cardiovascular safety (hERG/telemetry) | Crossover design | 4-8 | ~$200K |
Why Beagles?
Docile temperament
Tolerate handling, restraint, and painful procedures without biting handlers.
Manageable size (8-14 kg)
Cost-effective housing. Allows serial blood sampling and surgical implantation.
Cardiovascular similarity
Beagle cardiac electrophysiology closely models human responses (ICH S7A/S7B).
Regulatory precedent
Decades of baseline data. Regulators expect beagle data; unfamiliar species raise questions.
Pack mentality
Tolerate group housing better than many breeds, reducing facility costs.
Purpose-bred consistency
Genetically standardized. 'Marshall Beagle' is de facto industry standard.
International Trade
The beagle trade is global. Marshall BioResources operates facilities in at least 7 countries. Beagles are shipped internationally via air freight — the Copenhagen route alone moved 6,000+ dogs annually before it was disrupted in 2023. The EU uses approximately 5,000 dogs per year in research (2022 data), with the UK adding ~2,600 procedures involving dogs annually.